Immunopharmacology group
The research group Immunopharmacology focusses on the effects of various peptidase inhibitors (including dipeptidyl peptidase IV (CD26) and aminopeptidase N (CD13)), intravenous immunoglobulin preparations (IVIG), zinc preparations and regulatory cytokines (TGF-β, IL -10, IL-16, IL-35) on the activation, differentiation, and proliferation of T lymphocytes in vitro and in vivo.
In addition, we participate in the development of new diagnostic test systems for the detection of autoantibodies.